Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Relevance of αβ-DNTs as Prognostic Factor on Clinical Outcome and Role on Tumor Surveillance in Haematological Diseases and Solid Tumor: Preliminary Evaluations

Giacoma De Tullio, MSc, Carla Minoia, MD, Margherita Gigante, PhD, Sabino Strippoli, MD, Simona Serratì, PhD, Giacomo Loseto, MD, Rosa Angarano, MD, Nicola Sgherza, MD, Vincenza De Fazio, MD, Antonello Rana, MD, Angela Iacobazzi, MD, Michele Guida, MD, Elena Ranieri, PhD, Pasquale Iacopino, MD, Attilio Guarini

Blood (2014) 124 (21): 3840.

https://doi.org/10.1182/blood.V124.21.3840.3840

Published: 2014

Journal Articles

Cancer Associated Fibroblasts in Multiple Myeloma: The Urokinase Receptor System in Tumor Growth Regulation

Simona Serratì, Carla Minoia, Anastasia Chilla, Anna Laurenzana, Francesca Margheri, Maria Antonia Frassanito, Nicola Sgherza, Giacoma De Tullio, Angelo Vacca, MD PhD, Pasquale Iacopino, MD, Mario Del Rosso, Gabriella Fibbi, Attilio Guarini

Blood (2014) 124 (21): 5687.

https://doi.org/10.1182/blood.V124.21.5687.5687

Published: 2014

Journal Articles

The Functional Attitude and The Predictive Role Of An Unconventional Subset Of T Cells In Clinical Outcome Of Lymphoma Patients: αβ-Double Negative T Cells, Preliminary Data Of a Prospective Study

Giacoma De Tullio, MSc, Carla Minoia, MD, Simona Serratì, PhD, Francesca Merchionne, MD, Giacomo Loseto, MD, Angela La Pietra, MD, Antonello Rana, MD, Angela Iacobazzi, MD, Pasquale Iacopino, MD, Attilio Guarini, MD

Blood (2013) 122 (21): 4506.

https://doi.org/10.1182/blood.V122.21.4506.4506

Published: 2013

Journal Articles

Mobilizing Chemotherapy Followed by G-CSF, Additioned by Plerixafor on Demand, Is Safe and Allows Both Adequate PBSC (Peripheral Blood Stem Cell) Collection and Safe ASCT (Autologous Stem Cell Transplantation) In Multiple Myeloma and Lymphoma Patients

Immacolata Attolico, Vincenzo Pavone, MD, MD, CH, Angelo Ostuni, Maurizio Musso, Alessandra Crescimanno, Massimo Martino, MD, Pasquale Iacopino, Giuseppe Milone, MD, Patrizia Tedeschi, Attilio Olivieri

Blood (2010) 116 (21): 2257.

https://doi.org/10.1182/blood.V116.21.2257.2257

Published: 2010

Journal Articles

Increases In Mirna-145 and Mirna-146a Expression In Patients with IPSS Lower-Risk Myelodysplastic Syndromes and Del(5q) Treated with Lenalidomide.

Esther Natalie Oliva, MD, Francesco Nobile, MD, Pasquale Iacopino, MD, Giuliana Alimena, MD, Francesco Di Raimondo, Giuseppe A Palumbo, MD, Carmelo Laganà, Maria Grazia D'Errigo, BSc, Roberto Latagliata, MD, Maria Cuzzola, BSc

Blood (2010) 116 (21): 3631.

https://doi.org/10.1182/blood.V116.21.3631.3631

Published: 2010

Journal Articles

Is Antifungal Prophylaxis Useful In Stem Cell Transplantation (SCT) During Hospitalization?.

Giuseppe Irrera, MD, Messina Giuseppe, MD, Giuseppe Console, MD, Massimo Martino, MD, Cuzzola Maria, Antonella Meliadò, Pasquale Iacopino

Blood (2010) 116 (21): 4541.

https://doi.org/10.1182/blood.V116.21.4541.4541

Published: 2010

Journal Articles

Imatinib Is Safe and Effective In Patients with Refractory Chronic Graft Versus Host Disease: Analysis of Two Consecutive Prospective GITMO* Studies.*Gruppo Italiano Trapianto Midollo Osseo

Attilio Olivieri, Michele Cimminiello, MD, PhD, Franco Locatelli, MD, FRCPath, Marco Zecca, Paolo Corradini, MD, Francesca Patriarca, Nicola Mordini, Pasquale Iacopino, Amedea Donelli, MD, Carmine Selleri, MD, Manuela Badiali, Giovanna Lucchini, MD, Guido Gini, Pietro Leoni, MD, Alberto Bosi, Andrea Bacigalupo, MD

Blood (2010) 116 (21): 246.

https://doi.org/10.1182/blood.V116.21.246.246

Published: 2010

Journal Articles

Gene Expression Changes in Bone Marrow of MDS Patients with Del(5q) During Lenalidomide Treatment.

Esther Natalie Oliva, MD, Maria Cuzzola, Roberto Latagliata, MD, Francesca Ronco, MD, D'Errigo Maria Grazia, Morabito Fortunato, MD, Galimberti Sara, MD, Enrico Balleari, MD, Giorgina Specchia, MD, Agostino Cortelezzi, MD, Antonella Poloni, MD, Carlo Finelli, MD, Giuliana Alimena, Pasquale Iacopino, MD, Carmelo Laganà, MD, Francesco Mendicino, MD, Filippo Rodà, MD, Francesco Nobile, MD

Blood (2009) 114 (22): 2622.

https://doi.org/10.1182/blood.V114.22.2622.2622

Published: 2009

Journal Articles

Imatinib as Salvage Therapy for Patients with Refractory cGVHD: the Interim Analysis of the Prospective GITMO* Multicenter Study*Gruppo Italiano Trapianto Di Midollo Osseo.

Attilio Olivieri, MD, Michele Cimminiello, Paolo Corradini, MD, Pasquale Iacopino, MD, Amedea Donelli, Nicola Mordini, Carmine Selleri, Vincenzo Pavone, Renato Fanin, Franco Locatelli, Andrea Bacigalupo, MD, Alberto Bosi, MD

Blood (2009) 114 (22): 3558.

https://doi.org/10.1182/blood.V114.22.3558.3558

Published: 2009

Journal Articles

Autologous Stem Cell Transplantation (ASCT) with Busulfan Plus Cyclophosfamide as Conditioning Regimen for Acute Myeloid Leucemia: Retrospective Experience (1991–2007) of Two Bone Marrow Transplant Unit

Giuseppe Irrera, Giuseppe Messina, Massimo Martino, Giuseppe Console, Giuseppe Milone, MD, Pasquale Iacopino

Blood (2008) 112 (11): 4453.

https://doi.org/10.1182/blood.V112.11.4453.4453

Published: 2008

Journal Articles

Gene Expression Profile (GEP) Analysis as a Tool to Control the Efficacy Dasatinib Treatment in Relapsed Imatinib-Resistant CML Patients Previously Undergone to Allogeneic Stem Cell Transplantation. Preliminary Data of a Single Institution

Bruno Martino, MD, Maria Cuzzola, Carmela Rigolino, Domenica Ielo, Antonio Marino, MD, Francesco Nobile, Pasquale Iacopino, MD

Blood (2008) 112 (11): 4260.

https://doi.org/10.1182/blood.V112.11.4260.4260

Published: 2008

Journal Articles

Radioimmunotherapy ( 90 Y-Zevalin®) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study.

Blood (2008) 112 (11): 1144.

https://doi.org/10.1182/blood.V112.11.1144.1144

Published: 2008

Journal Articles

Changes in Gene Expression Profiles during Treatment with Erythropoetic Growth Factors in Myelodysplastic Syndromes.

Esther N. Oliva, MD, Margherita Comis, MD, Pasquale Iacopino, MD, Mariella Cuzzola, BSc, Roberto Latagliata, MD, Marco Danova, MD, Bianca Rovati, MD, Giovanni Spampinato, Giuliana Alimena, MD, Ida Carmosino, MD, Massimo Breccia, MD, Francesco Nobile, MD

Blood (2007) 110 (11): 4609.

https://doi.org/10.1182/blood.V110.11.4609.4609

Published: 2007

NARROW

Relevance of αβ-DNTs as Prognostic Factor on Clinical Outcome and Role on Tumor Surveillance in Haematological Diseases and Solid Tumor: Preliminary Evaluations

Cancer Associated Fibroblasts in Multiple Myeloma: The Urokinase Receptor System in Tumor Growth Regulation

The Functional Attitude and The Predictive Role Of An Unconventional Subset Of T Cells In Clinical Outcome Of Lymphoma Patients: αβ-Double Negative T Cells, Preliminary Data Of a Prospective Study

Mobilizing Chemotherapy Followed by G-CSF, Additioned by Plerixafor on Demand, Is Safe and Allows Both Adequate PBSC (Peripheral Blood Stem Cell) Collection and Safe ASCT (Autologous Stem Cell Transplantation) In Multiple Myeloma and Lymphoma Patients

Increases In Mirna-145 and Mirna-146a Expression In Patients with IPSS Lower-Risk Myelodysplastic Syndromes and Del(5q) Treated with Lenalidomide.

Is Antifungal Prophylaxis Useful In Stem Cell Transplantation (SCT) During Hospitalization?.

Imatinib Is Safe and Effective In Patients with Refractory Chronic Graft Versus Host Disease: Analysis of Two Consecutive Prospective GITMO* Studies.*Gruppo Italiano Trapianto Midollo Osseo

Gene Expression Changes in Bone Marrow of MDS Patients with Del(5q) During Lenalidomide Treatment.

Imatinib as Salvage Therapy for Patients with Refractory cGVHD: the Interim Analysis of the Prospective GITMO* Multicenter Study*Gruppo Italiano Trapianto Di Midollo Osseo.

Autologous Stem Cell Transplantation (ASCT) with Busulfan Plus Cyclophosfamide as Conditioning Regimen for Acute Myeloid Leucemia: Retrospective Experience (1991–2007) of Two Bone Marrow Transplant Unit

Gene Expression Profile (GEP) Analysis as a Tool to Control the Efficacy Dasatinib Treatment in Relapsed Imatinib-Resistant CML Patients Previously Undergone to Allogeneic Stem Cell Transplantation. Preliminary Data of a Single Institution

Radioimmunotherapy ( 90 Y-Zevalin®) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study.

Changes in Gene Expression Profiles during Treatment with Erythropoetic Growth Factors in Myelodysplastic Syndromes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only